Will seek regulatory approval
Good news for parents worried about sending their kids to school amid the pandemic.
Pfizer announcing today its COVID-19 vaccine works for children ages 5 to 11.
The next step is getting approval from regulators in the U.S.. Britain and Europe to begin with.
Pfizer studied the vaccine in more than 2,000 kindergartners and elementary school-aged kids.
It gave them about a third of the typical dose and found they developed antibody levels just as strong as teens and young adults.

Man Dies in Lincoln House Fire
Potential Niagara Parks Strike
Man Charged with Possessing Child Porn
Be Wary of Spring Time Scams: NRP
Man Killed Walking Along QEW
Senior Charged with Hate Speech Crime
Medical Researchers Gather in Niagara
Province Passes Gov't Reform Act